Cite
HARVARD Citation
Li, S. et al. (2022). Triterpenoid ursolic acid drives metabolic rewiring and epigenetic reprogramming in treatment/prevention of human prostate cancer. Molecular carcinogenesis. 61 (1), pp. 111-121. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Li, S. et al. (2022). Triterpenoid ursolic acid drives metabolic rewiring and epigenetic reprogramming in treatment/prevention of human prostate cancer. Molecular carcinogenesis. 61 (1), pp. 111-121. [Online].